[ALNY] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -15.69%
YoY- -25.94%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 2,069 29,907 21,899 37,924 17,096 15,932 18,960 -77.13%
PBT -244,837 -163,481 -141,276 -142,227 -122,937 -118,420 -107,290 73.24%
Tax 445 79 -62 -7,949 -3,296 -2,577 -2,128 -
NP -245,282 -163,560 -141,214 -142,227 -122,937 -118,420 -107,290 73.45%
Tax Rate - - - - - - - -
Total Cost 247,351 193,467 163,113 180,151 140,033 134,352 126,250 56.51%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -11,855.10 -546.90 -644.84 -375.03 -719.10 -743.28 -565.88 658.54%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 55.69%
EPS Diluted -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 55.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.